Pfizer PFE

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Pfizer's ( PFE ) price target is hiked a buck to $29 at MKM Partners as the earlier-than-expected Zoetis (ZTS) spinoff has the team cutting their 2013 EPS forecast to $2.17 from $2.23, but raising ...

      Headlines

      Fri, 24 May 2013

      Pfizer 's ( PFE ) price target is hiked a buck to $29 at MKM Partners as the earlier-than-expected Zoetis ( ZTS ) spinoff has the team cutting

    2. Pfizer Has Potential To Grow Despite Decreasing Sales

      Headlines

      Fri, 24 May 2013

      By Alpha Hunter: Pfizer ( PFE ) is the world's largest research-based pharmaceutical company. It discovers, manufactures and leads the global market in

    3. Another Look At Marketing Vs. R&D In Pharma

      Headlines

      Thu, 23 May 2013

      Fierce had a recent article on marketing budgets in the business, and they take Pfizer 's ( PFE ) numbers as a test case. That's actually a really good example: Pfizer is known as a mighty marketing machine, and for a long time they had what must

    4. MannKind's Afrezza And The Oramed Threat

      Headlines

      Thu, 23 May 2013

      Renauer: My last article concerning MannKind Corp. ( MNKD ) was a discussion of how its Afrezza will succeed where Pfizer 's ( PFE ) Exubera failed. I still believe it can, but I didn't give MannKind's competitive landscape as much attention

    5. RPT-FEATURE- Pfizer takes its shot at a vaccine for evasive superbug

      Headlines

      Thu, 23 May 2013

      is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer .

    6. Pfizer takes its shot at a vaccine for evasive superbug

      Headlines

      Thu, 23 May 2013

      CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer .

    7. FEATURE- Pfizer takes its shot at a vaccine for evasive superbug

      Headlines

      Thu, 23 May 2013

      is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer .

    8. UPDATE 2- Pfizer to spin off Zoetis stake to shareholders

      Headlines

      Wed, 22 May 2013

      May 22 (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7...

    9. Pfizer to spin off Zoetis stake to shareholders

      Headlines

      Wed, 22 May 2013

      (Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount.

    10. BRIEF- Pfizer up in premarket after plans to unwind remaining majority stake in Zoetis

      Headlines

      Wed, 22 May 2013

      NEW YORK, May 22 (Reuters) - Pfizer Inc : * Up 2.2 percent to $29.40 in premarket after plans to unwind remaining majority stake in Zoetis

    « Prev12345Next »
    Content Partners